Literature DB >> 2583222

Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules.

T Uchiyama1, K Imanishi, S Saito, M Araake, X J Yan, H Fujikawa, H Igarashi, H Kato, F Obata, N Kashiwagi.   

Abstract

Toxic shock syndrome toxin-1 (TSST-1)-binding assay using 125I-labeled TSST-1 showed the presence of specific TSST-1 binding in a B cell fraction of human peripheral blood mononuclear cells and L cells transfected with DR2 genes or DR4 genes but not in a T cell fraction and control L cells. Fixation with paraformaldehyde, an inhibitor of antigen processing, did not remove TSST-1-binding activity of the transfectants. Binding of 125I-labeled TSST-1 to the transfectants was reduced by an anti-DR monoclonal antibody. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed the presence of a single band with TSST-1-binding activity and the same migration pattern as DR heterodimers. TSST-1-induced T cell responses, proliferation and interleukin 2 (IL2) production were observed in the presence of the transfectants but not in the presence of control L cells, while concanavalin A-induced IL2 production was observed in the presence of either the transfectants or control L cells. Presence of an anti-DR monoclonal antibody inhibited the TSST-1-induced responses. Paraformaldehyde-fixed Daudi cells were effective in supporting TSST-1-induced IL2 production by T cells. These results indicate that HLA class II molecules directly bind intact TSST-1 and perform an essential role as the TSST-1-binding structures on accessory cells in T cell activation by the toxin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2583222     DOI: 10.1002/eji.1830191007

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Relative abilities of distinct isotypes of human major histocompatibility complex class II molecules to bind streptococcal pyrogenic exotoxin types A and B.

Authors:  K Imanishi; H Igarashi; T Uchiyama
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

2.  Relative activities of distinct isotypes of murine and human major histocompatibility complex class II molecules in binding toxic shock syndrome toxin 1 and determination of CD antigens expressed on T cells generated upon stimulation by the toxin.

Authors:  T Uchiyama; S Saito; H Inoko; X J Yan; K Imanishi; M Araake; H Igarashi
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

Review 3.  Microbial "superantigens".

Authors:  M L Misfeldt
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

4.  Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen.

Authors:  N Takahashi; H Kato; K Imanishi; K Miwa; S Yamanami; H Nishida; T Uchiyama
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

5.  Production of tumour necrosis factors by human T cells stimulated by a superantigen, toxic shock syndrome toxin-1.

Authors:  H Akatsuka; K Imanishi; K Inada; H Yamashita; M Yoshida; T Uchiyama
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

6.  Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).

Authors:  A Norrby-Teglund; D Newton; M Kotb; S E Holm; M Norgren
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Purification and partial characterization of a product from Yersinia pseudotuberculosis with the ability to activate human T cells.

Authors:  T Miyoshi-Akiyama; K Imanishi; T Uchiyama
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Involvement of HLA class II molecules in acquisition of staphylococcal enterotoxin A-binding activity and accessory cell activity in activation of human T cells by related toxins in vascular endothelial cells.

Authors:  T Uchiyama; M Araake; X J Yan; Y Miyanaga; H Igarashi
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

9.  Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B.

Authors:  A Norrby-Teglund; M Norgren; S E Holm; U Andersson; J Andersson
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.